Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pancrex V 125mg capsules
0109040N0BBACAH
|
Pancrex | Pancreatin | Gastro-Intestinal System | 408 |
|
Senokot 7.5mg tablets 12 Years Plus (Reckitt)
0106020M0BBAKAC
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 389 |
|
Co-magaldrox 200mg/175mg/5ml oral suspension sugar free
0101010G0AAAGAG
|
Co-magaldrox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | 387 |
|
Mezzopram 40mg dispersible gastro-resistant tablets (Sandoz)
0103050P0BGACAP
|
Mezzopram | Omeprazole | Gastro-Intestinal System | 386 |
|
Liquid paraffin liquid
0106030P0AAABAB
|
Liq paraf (Systemic) | Liquid paraffin | Gastro-Intestinal System | 375 |
|
Lansoprazole 30mg/5ml oral solution
0103050L0AAAJAJ
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | 373 |
|
Belladonna medicated plaster 28cm x 17.5cm
0102000H0AAANAN
|
Belladonna (Alkaloids) | Belladonna alkaloids | Gastro-Intestinal System | 359 |
|
Resolor 1mg tablets
0106070A0BBAAAA
|
Resolor | Prucalopride | Gastro-Intestinal System | 359 |
|
Zinc oxide 6.6% / Lidocaine 0.7% cream
0107010N0AAAJAJ
|
Lidocaine hydrochloride (Rectal) | Lidocaine hydrochloride | Gastro-Intestinal System | 358 |
|
Mesalazine 1g gastro-resistant tablets
0105010B0AABCBC
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 352 |
|
Magnesium hydroxide 8% oral suspension
0106040J0AAAIAI
|
Magnesium hydroxide (Laxative) | Magnesium hydroxide | Gastro-Intestinal System | 338 |
|
Moventig 25mg tablets
0106060B0BBABAB
|
Moventig | Naloxegol | Gastro-Intestinal System | 337 |
|
Glycopyrronium bromide 5mg/5ml oral suspension
0102000L0AABGBG
|
Glycopyrronium bromide (Oral) | Glycopyrronium bromide | Gastro-Intestinal System | 331 |
|
Cholurso 500mg tablets
0109010U0BFAABK
|
Cholurso | Ursodeoxycholic acid | Gastro-Intestinal System | 330 |
|
Dulcolax Pico Twelve 5mg/5ml liquid
0106020P0BDADAB
|
Dulcolax (Sodium picosulfate) | Sodium picosulfate | Gastro-Intestinal System | 326 |
|
Nexium 10mg gastro-resistant granules sachets
0103050E0BBADAE
|
Nexium | Esomeprazole | Gastro-Intestinal System | 324 |
|
Mepradec 10mg gastro-resistant capsules
0103050P0BFAAAF
|
Mepradec | Omeprazole | Gastro-Intestinal System | 320 |
|
Magnesium trisilicate oral suspension
0101010J0AAAAAA
|
Magnesium trisilicate | Magnesium trisilicate | Gastro-Intestinal System | 306 |
|
Preparation H ointment
010701000BJBGAC
|
Proprietary compound preparation BNF 0107010 | Other soothing haemorrhoidal preparations | Gastro-Intestinal System | 304 |
|
Rennie Deflatine chewable tablets
010102100BBABAB
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 303 |
|
Imodium Dual Action Relief tablets
0104020P0BBACAA
|
Imodium Plus | Loperamide hydrochloride and simeticone | Gastro-Intestinal System | 302 |
|
Nalcrom 100mg capsules (Sanofi)
0105040A0BBAAAA
|
Nalcrom | Sodium cromoglicate | Gastro-Intestinal System | 301 |
|
Imodium 1mg/5ml oral solution
0104020L0BBABAB
|
Imodium | Loperamide hydrochloride | Gastro-Intestinal System | 298 |
|
Rennie Peppermint chewable tablets
010102100BBAQAF
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 298 |
|
Bisacodyl 2.5mg/5ml oral suspension
0106020C0AAAVAV
|
Bisacodyl | Bisacodyl | Gastro-Intestinal System | 297 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.